Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

SeaStar Medical Holding Corp

$2.90 -1.36% NASDAQ: ICU · 15-min delayed
  • DENVER, Colorado
  • Public · NASDAQ: ICU
  • 17 employees
$11.8MMarket cap
$1.2MRevenue · FY2025
-$12.2MNet income
17Employees
ICUNASDAQ
2022IPO

About SeaStar Medical Holding Corp

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$1.2M
Net income
-$12.2M
Total assets
$14.2M
Market cap
$11.8M
Gross margin
95.7%
Operating margin
-986.6%
Net margin
-984.6%

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$1.2M
Cost of revenue
$53.0K
Gross profit
$1.2M
Operating expenses
$13.4M
Operating income
-$12.2M
Income tax
$3.0K
Net income
-$12.2M
EPS (basic)
$-5.86

Balance sheet

Total assets
$14.2M
Current assets
$13.6M
Total liabilities
$3.7M
Current liabilities
$3.7M
Shareholders’ equity
$10.4M

Cash flow

Operating cash flow
-$13.6M
Investing cash flow
-$10.2M
Financing cash flow
$23.8M
Net cash flow
$0

Statements via Polygon.io (SEC filings)

NASDAQ: ICU
$2.90 -1.36%

15-minute delayed · data by Polygon.io

Past year

$2.21 $13.00

52-week range

Market cap
$11.8M
Shares outstanding
4.1M
Open
Day range
Prev close
Volume
IPO date
Oct 31, 2022

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

  • Reported a net loss of $12.2M in FY2025.
  • Gross margin of 95.7%, net margin -984.6%.
  • Trading 78% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review SeaStar Medical Holding Corp.

Write a review
Newsroom

News about SeaStar Medical Holding Corp

News & sentiment via Polygon.io

Explore

Similar companies

Browse all →